Oncogene, 1476-5594

Journal

More filtering options
  1. 2017
  2. 2016
  3. Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML

    O Lindblad, Cordero, E., Puissant, A., Macaulay, L., Ramos, A., Kabir, N. N., J Sun, J Vallon-Christersson, Haraldsson, K., Hemann, M. T., Åke Borg, F Levander, Stegmaier, K., K Pietras, L Rönnstrand & J U Kazi 2016 Sep 29 In : Oncogene. 35, 39, p. 5119-5131 13 p.

    Research output: Contribution to journalArticle

  4. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer

    E Englund, M Bartoschek, Reitsma, B., Jacobsson, L., Escudero-Esparza, A., Orimo, A., K Leandersson, C Hagerling, A Aspberg, Storm, P., M Okroj, H Mulder, K Jirström, K Pietras & A M Blom 2016 In : Oncogene. 35, 43, p. 5585-5596 12 p.

    Research output: Contribution to journalArticle

  5. 2015
  6. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.

    Kobayashi, T., Katarzyna Masoumi & Ramin Massoumi 2015 In : Oncogene. 34, 17, p. 2251-2260

    Research output: Contribution to journalArticle

  7. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    Busch, S., Acar, A., Magnusson, Y., Gregersson, P., Lisa Rydén & Landberg, G. 2015 In : Oncogene. 34, 1, p. 27-38

    Research output: Contribution to journalArticle

  8. 2014
  9. 2013
  10. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.

    Ahlqvist, K., Saamarthy, K., Syed Khaja, A. S., Anders Bjartell & Ramin Massoumi 2013 In : Oncogene. 32, 12, p. 1601-1608

    Research output: Contribution to journalArticle

  11. MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer

    Johansson, J., Berg, T., Kurzejamska, E., Pang, M-F., Tabor, V., Jansson, M., Roswall, P., Kristian Pietras, Sund, M., Religa, P. & Fuxe, J. 2013 In : Oncogene. 32, 50, p. 5614-5624

    Research output: Contribution to journalArticle

  12. 2012
  13. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

    Santo, E. E., Ebus, M. E., Koster, J., Schulte, J. H., Lakeman, A., van Sluis, P., Vermeulen, J., David Gisselsson Nord, Ingrid Øra, Lindner, S., Buckley, P. G., Stallings, R. L., Vandesompele, J., Eggert, A., Caron, H. N., Versteeg, R. & Molenaar, J. J. 2012 In : Oncogene. 31, 12, p. 1571-1581

    Research output: Contribution to journalArticle

  14. The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer

    Brennan, D. J., O'Connor, D. P., Laursen, H., McGee, S. F., McCarthy, S., Zagozdzon, R., Rexhepaj, E., Culhane, A. C., Martin, F. M., Duffy, M. J., Landberg, G., Lisa Rydén, Hewitt, S. M., Kuhar, M. J., Bernards, R., Millikan, R. C., Crown, J. P., Karin Jirström & Gallagher, W. M. 2012 In : Oncogene. 31, 30, p. 3483-3494

    Research output: Contribution to journalArticle

  15. 2011
  16. Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.

    Storm, P., Aits, S., Puthia, M. K., Urbano, A., Northen, T., Powers, S., Bowen, B., Chao, Y., Reindl, W., Lee, D. Y., Sullivan, N. L., Zhang, J., Trulsson, M., Yang, H., Watson, J. D. & Catharina Svanborg 2011 In : Oncogene. 30, p. 4765-4779

    Research output: Contribution to journalArticle

  17. GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma

    Kuphal, S., Shaw-Hallgren, G., Eberl, M., Karrer, S., Aberger, F., Bosserhoff, A. K. & Ramin Massoumi 2011 In : Oncogene. 30, 44, p. 4523-4530

    Research output: Contribution to journalArticle

  18. Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis

    Rohlin, A., Engwall, Y., Fritzell, K., Goransson, K., Bergsten, A., Einbeigi, Z., Mef Nilbert, Karlsson, P., Bjork, J. & Nordling, M. 2011 In : Oncogene. 30, 50, p. 4977-4989

    Research output: Contribution to journalArticle

  19. 2010
  20. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

    Ringnér, M. & 20 others Mestdagh, P., Fredlund, E., Pattyn, F., Rihani, A., Van Maerken, T., Vermeulen, J., Kumps, C., Menten, B., De Preter, K., Schramm, A., Schulte, J., Noguera, R., Schleiermacher, G., Janoueix-Lerosey, I., Laureys, G., Powel, R., Nittner, D., Marine, J-C., Speleman, F. & Vandesompele, J. 2010 In : Oncogene. 29, 24, p. 3583-3592

    Research output: Contribution to journalArticle

  21. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression

    Iadevaia, V., Caldarola, S., Biondini, L., Gismondi, A., Stefan Karlsson, Dianzani, I. & Loreni, F. 2010 In : Oncogene. 29, 40, p. 5490-5499

    Research output: Contribution to journalArticle

  22. 2009
  23. Hematopoietic stem cell ageing is uncoupled from p16(INK4A)-mediated senescence.

    Attema, J., Kees-Jan Pronk, Norddahl, G., Nygren, J. & David Bryder 2009 In : Oncogene. 28, p. 2238-2243

    Research output: Contribution to journalArticle

  24. 2008
  25. A novel fusion 5 ' AFF3/3 ' BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma

    Impera, L., Albano, F., Lo Cunsolo, C., Funes, S., Iuzzolino, P., Laveder, F., Panagopoulos, I., Rocchi, M. & Storlazzi, C. T. 2008 In : Oncogene. 27, 47, p. 6187-6190

    Research output: Contribution to journalArticle

  26. 2007
  27. Arsenic trioxide-induced neuroblastoma cell death is accompanied by proteolytic activation of nuclear Bax.

    Jenny Karlsson, Alexander Pietras, Beckman, S., Pettersson, H., Christer Larsson & Sven Påhlman 2007 In : Oncogene. 26, 42, p. 6150-6159

    Research output: Contribution to journalArticle

  28. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis

    McBryan, J., Jillian Howlin, Kenny, P. A., Shioda, T. & Martin, F. 2007 In : Oncogene. 26, 44, p. 6406-6419

    Research output: Contribution to journalArticle

  29. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

    Göran B Jönsson, Dahl, C., Johan Staaf, Therese Törngren, Pär-Ola Bendahl, Markus Ringnér, Guldberg, P. & Åke Borg 2007 In : Oncogene. 26, 32, p. 4738-4748

    Research output: Contribution to journalArticle

  30. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells

    Perks, C. M., Vernon, E. G., Ann Rosendahl, Tonge, D. & Holly, J. M. P. 2007 In : Oncogene. 26, 40, p. 5966-5972

    Research output: Contribution to journalArticle

  31. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling

    Herzig, M., Savarese, F., Novatchkova, M., Semb, H. & Christofori, G. 2007 In : Oncogene. 26, 16, p. 2290-2298

    Research output: Contribution to journalArticle

  32. 2006
  33. A gene fusion network in human neoplasia.

    Mattias Höglund, Frigyesi, A. & Felix Mitelman 2006 In : Oncogene. 25, 18, p. 2674-2678

    Research output: Contribution to journalArticle

  34. CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis

    Jillian Howlin, McBryan, J., Napoletano, S., Lambe, T., McArdle, E., Shioda, T. & Martin, F. 2006 In : Oncogene. 25, 10, p. 1532-1542

    Research output: Contribution to journalArticle

  35. Endogenous production of leukotriene D(4) mediates autocrine survival and proliferation via CysLT(1) receptor signalling in intestinal epithelial cells.

    Paruchuri, S., Mezhybovska, M., Juhas, M. & Anita Sjölander 2006 In : Oncogene. 25, 50, p. 6660-6665

    Research output: Contribution to journalArticle

  36. 2005
  37. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.

    Wegiel, B., Anders Bjartell, Ekberg, J., Gadaleanu, V., Brunhoff, C. & Jenny L Persson 2005 In : Oncogene. 24, 42, p. 6385-6393

    Research output: Contribution to journalArticle

  38. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter

    Cismasiu, V., Adamo, K., Gecewicz, J., Duque, J., Lin, Q. & Avram, D. 2005 In : Oncogene. 24, 45, p. 6753-6764

    Research output: Contribution to journalArticle

  39. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

    Svensson Månsson, S., Karin Jirström, Lisa Rydén, Roos, G., Emdin, S., Ostrowski, M. & Landberg, G. 2005 In : Oncogene. 24, 27, p. 4370-4379

    Research output: Contribution to journalArticle

  40. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.

    Heidenblad, M., David Lindgren, Veltman, J. A., Tord Jonson, Mahlamäki, E. H., Gorunova, L., van Kessel, A. G., Schoenmakers, E. F. P. M. & Mattias Höglund 2005 In : Oncogene. 24, 10, p. 1794-1801

    Research output: Contribution to journalArticle

  41. The role of Smad signaling in hematopoiesis.

    Jonas Larsson & Stefan Karlsson 2005 In : Oncogene. 24, 37, p. 5676-5692

    Research output: Contribution to journalReview article

  42. Wnt-5a has tumor suppressor activity in thyroid carcinoma

    Kremenevskaja, N., von Wasielewski, R., Rao, A. S., Schofl, C., Tommy Andersson & Brabant, G. 2005 In : Oncogene. 24, 13, p. 2144-2154

    Research output: Contribution to journalArticle

  43. 2004
  44. Microarray expression profiling in melanoma reveals a BRAF mutation signature

    Pavey, S., Johansson, P., Packer, L., Taylor, J., Stark, M., Pollock, P. M., Walker, G. J., Boyle, G. M., Harper, U., Cozzi, S. J., Hansen, K., Yudt, L., Schmidt, C., Hersey, P., Ellem, K. A. O., O'Rourke, M. G. E., Parsons, P. G., Meltzer, P., Markus Ringnér & Hayward, N. K. 2004 In : Oncogene. 23, 23, p. 4060-4067

    Research output: Contribution to journalArticle

  45. Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.

    Ekberg, J., Landberg, G., Caroline Wigerup, Richter, J., Wolgemuth, D. J. & Jenny L Persson 2004 In : Oncogene. 23, 56, p. 9082-9089

    Research output: Contribution to journalArticle

  46. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.

    Obad, S., Brunnström, H., Johan Vallon-Christersson, Åke Borg, Kristina Drott & Urban Gullberg 2004 In : Oncogene. 23, 23, p. 4050-4059

    Research output: Contribution to journalArticle

  47. 2003
  48. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value

    Vandesompele, J., Edsjö, A., De Preter, K., Håkan Axelson, Speleman, F. & Sven Påhlman 2003 In : Oncogene. 22, 3, p. 456-460

    Research output: Contribution to journalArticle

  49. 2002
  50. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas

    Yang, K., Lui, W. O., Xie, Y. T., Zhang, A. J., Skytting, B., Nils Mandahl, Larsson, C. & Larsson, O. 2002 In : Oncogene. 21, 26, p. 4181-4190

    Research output: Contribution to journalArticle

  51. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers

    Archey, W. B., McEachern, K. A., Robson, M., Offit, K., Vaziri, S. A. J., Casey, G., Åke Borg & Arrick, B. A. 2002 In : Oncogene. 21, 46, p. 7034-7041

    Research output: Contribution to journalArticle

  52. SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF-beta receptor

    Ekman, S., Kallin, A., Engström, U., Heldin, C-H. & Lars Rönnstrand 2002 In : Oncogene. 21, p. 1870-1875

    Research output: Contribution to journalArticle

  53. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

    Loden, M., Stighall, M., Nielsen, H. N., Roos, G., Emdin, S. O., Ostlund, H. & Landberg, G. 2002 In : Oncogene. 21, 30, p. 4680-4690

    Research output: Contribution to journalArticle

  54. 2001
  55. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Ladanyi, M., Lui, M. Y., Antonescu, C. R., Krause-Boehm, A., Meindl, A., Argani, P., Healey, J. H., Ueda, T., Yoshikawa, H., Meloni-Ehrig, A., Sorensen, P. H. B., Fredrik Mertens, Nils Mandahl, van den Berghe, H., Sciot, R., Cin, P. & Bridge, J. 2001 In : Oncogene. 20, 1, p. 48-57

    Research output: Contribution to journalArticle

  56. 1999
  57. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein

    Sjöblom, T., Boureux, A., Lars Rönnstrand, Heldin, C-H., Ghysdael, J. & Östman, A. 1999 In : Oncogene. 18, 50, p. 7055-7062

    Research output: Contribution to journalArticle

  58. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding

    Ekman, S., Thuresson, E. R., Heldin, C-H. & Lars Rönnstrand 1999 In : Oncogene. 18, 15, p. 2481-2488

    Research output: Contribution to journalArticle

  59. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

    Lennartsson, J., Blume-Jensen, P., Hermanson, M., Pontén, E., Carlberg, M. & Lars Rönnstrand 1999 In : Oncogene. 18, 40, p. 5546-5553

    Research output: Contribution to journalArticle

  60. SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis

    Lars Rönnstrand, Arvidsson, A-K., Kallin, A., Rorsman, C., Hellman, U., Engström, U., Wernstedt, C. & Heldin, C-H. 1999 In : Oncogene. 18, 25, p. 3696-3702

    Research output: Contribution to journalArticle

  61. 1998
  62. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

    Svedberg, H., Chylicki, K., Bo Baldetorp, Rauscher, F. J. . & Urban Gullberg 1998 In : Oncogene. 16, 7, p. 925-932

    Research output: Contribution to journalArticle

Previous 1 2 Next